Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Lobular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Large-scale testing (Phase 3)Study completedNCT02620280
What this trial is testing

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

Who this might be right for
Invasive Ductal Breast Carcinoma
Fondazione Michelangelo 278
Testing effectiveness (Phase 2)Study completedNCT01417286
What this trial is testing

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Who this might be right for
Inflammatory Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma+7 more
Rutgers, The State University of New Jersey 69
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Very early researchStudy completedNCT04341129
What this trial is testing

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Who this might be right for
Breast NeoplasmsBreast DiseasesBreast Fibroadenoma+1 more
University of Chicago 50
Not applicableStudy completedNCT00859157
What this trial is testing

Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast CancerPainPerioperative/Postoperative Complications
University of California, Davis 74
Testing effectiveness (Phase 2)Study completedNCT05545150
What this trial is testing

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Bilateral Breast CarcinomaBreast Ductal Carcinoma In Situ+3 more
Northwestern University 113
Large-scale testing (Phase 3)Temporarily pausedNCT06671912
What this trial is testing

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+4 more
Alliance for Clinical Trials in Oncology 1,556
Not applicableEnded earlyNCT04088435
What this trial is testing

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, Invasive DuctalInvasive Mammary Carcinoma+2 more
University of Louisville 10
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT06067503
What this trial is testing

Biomarkers to Detect Endocrine Therapy Resistance

Who this might be right for
Metastatic CancerBreast CancerLobular Breast Carcinoma
University of Wisconsin, Madison 8
Not applicableStudy completedNCT00581750
What this trial is testing

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Who this might be right for
Breast CancerLobular CarcinomaInvasive Breast Cancer
Memorial Sloan Kettering Cancer Center 550
Early research (Phase 1)Study completedNCT01791478
What this trial is testing

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+3 more
Vanderbilt-Ingram Cancer Center 46
Not applicableStudy completedNCT01208974
What this trial is testing

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction

Who this might be right for
Breast CancerDuctal Carcinoma
University of Miami 21
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Not applicableStudy completedNCT01060085
What this trial is testing

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Dartmouth-Hitchcock Medical Center 51
Testing effectiveness (Phase 2)Ended earlyNCT02137252
What this trial is testing

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Who this might be right for
Invasive Breast Cancer (Stage I-III)Ductal Carcinoma in SituLobular Carcinoma in Situ+2 more
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Not applicableActive Not RecruitingNCT01644669
What this trial is testing

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma in Situ
Xoft, Inc. 1,200
Next Page